Here’s what you need to know:
1. With this patient engagement platform, physicians will be able to monitor patients suffering from irritable bowel syndrome with diarrhea. The platform’s services will include assessments of symptoms and treatment impact.
2. Allergan and SonarMD say that this patient engagement platform will also help to generate real-world data on the impact of various treatment options.
3. SonarMD has already developed a cloud-based care management platform for patients with other chronic illnesses, such as Crohn’s disease. This platform was created by gastroenterologist Lawrence Kosinski, MD.
More articles on gastroenterology and endoscopy:
Anti-inflammatory drug used for asthma, IBS may also treat liver disease: 5 study insights
Prometheus Laboratories launches new test to monitor vedolizumab: 3 notes
Clinical Genomics appoints 4 new experts to leadership team
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.